Skip to main content
OpenTrials

Clinical trial condition

NSCLC

Explore clinical trials studying NSCLC. Study availability and eligibility vary by location and protocol.

357 public trials 121 recruiting studies
Refine in advanced search Browse all conditions

NSCLC trial results

Active, Not Recruiting

Phase I Trial of Defactinib and VS-6766.

NCT03875820

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +27 more
Locations
  • The Christie NHS Foundation Trust Manchester, Greater Manchester, United Kingdom
  • The Royal Marsden NHS Foundation Trust Sutton, Surrey, United Kingdom
  • The Royal Marsden NHS Foundation Trust - Gynecology Unit London, United Kingdom
  • The Newcastle Upon Tyne Hospitals NHS Foundation Trust - Freeman Hospital Newcastle, United Kingdom
View Trial Details
Active, Not Recruiting

Study of Oral MRT-2359 in Selected Cancer Patients

NCT05546268

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +38 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • University of California San Diego San Diego, California, United States
  • Yale University New Haven, Connecticut, United States
  • University of Kansas Cancer Center Lawrence, Kansas, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

Neoadjuvant Platform Trial in Non-Small Cell Lung Cancer

NCT05714891

Conditions
NSCLC
Locations
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
  • Kingston Health Sciences Centre Kingston, Ontario, Canada
  • London Health Sciences Centre Research Inc. London, Ontario, Canada
  • Ottawa Hospital Research Institute Ottawa, Ontario, Canada
View Trial Details
Active, Not Recruiting

Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

NCT03808662

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +19 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Active, Not Recruiting

Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients

NCT04223596

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • Complejo Hospitalario de A Coruña A Coruña, Spain
  • Hospital General de Alicante Alicante, Spain
  • Hospital Regional Universitario de Málaga Málaga, Andalusia, Spain
  • Hospital Son Espases Palma de Mallorca, Balearic Islands, Spain
View all 15 locations
View Trial Details
Active, Not Recruiting

Adjuvant Treatment With Cisplatin-based Chemotherapy Plus Concomitant Atezolizumab in Patients With Stage I (Tumors ≥ 4cm), IIA, IIB, and Select Stage III [Any T1-3 N1-2 and T4N0-2] Resected Non-small Cell Lung Cancer (NSCLC) and the Clearance of Circulating Tumor DNA (ctDNA)

NCT04367311

Conditions
Lung Cancer, Lung Diseases, Lung Neoplasms, +6 more
Locations
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Summit Health Berkeley Heights, New Jersey, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
View Trial Details

Related conditions